← Leaderboards
Yoon Young Jang
Johns Hopkins University
$1,812,021
Attributed
$1,924,478
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $368.4K · FY2011–22$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,924,478 · 4
By mechanism
R01$1,105,314 · 1
R21$430,500 · 1
R43$224,914 · 1
R03$163,750 · 1
Top collaborators
- Zhizhong Yin1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Dorry Segev$40,743,790
- James A Tonascia$68,672,260
- Christine Marie Durand$23,429,807
- Chloe L Thio$13,807,555
- David L Thomas$44,227,388
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LineInduced Pluripotent Stem CellPharmaceutical PreparationsBaseLiver DiseasesTissuesDisease ModelCirrhosisIn VitroDesignCell ModelCellsLiverBiliary AtresiaBiliaryInnovationMedicalMutantChildhoodFibrosisLifeCharacteristicsHepatobiliaryDisease Phenotype
Grant awards (8)
Developing preclinical human iPSC-based HTS assays to identify therapeutic agents for biliary atresia$368,438
R01 · FY2022 · DK · contact PI
Developing preclinical human iPSC-based HTS assays to identify therapeutic agents for biliary atresia$368,438
R01 · FY2021 · DK · contact PI
Developing preclinical human iPSC-based HTS assays to identify therapeutic agents for biliary atresia$368,438
R01 · FY2020 · DK · contact PI
A human iPSC-based model of Biliary Atresia$81,875
R03 · FY2019 · HD · contact PI
A human iPSC-based model of Biliary Atresia$81,875
R03 · FY2018 · HD · contact PI
Ultraminiaturized microfluidics-based drug toxicity screening platform using iPSC$224,914
R43 · FY2013 · ES
DISEASE MODELING OF ALCOHOL RELATED HEPATOCELLULAR CARCINOMA USING PATIENT IPSCS$235,750
R21 · FY2012 · AA · contact PI
DISEASE MODELING OF ALCOHOL RELATED HEPATOCELLULAR CARCINOMA USING PATIENT IPSCS$194,750
R21 · FY2011 · AA · contact PI